22-05-2025
Globalpharma Exports to 18 Countries as UAE-Made Medicines Drive Global Expansion
Globalpharma, a subsidiary of Dubai Investments, is ramping up its international footprint with the production of over 120 pharmaceutical products now exported to 18 countries across Africa, the GCC, Eastern Europe, and Asia, according to a senior company official.
Mohamad Saeed Al Raqbani, General Manager of Dubai Investments Industries and Board Director at Globalpharma, outlined the company's ambitions to scale globally through advanced pharmaceutical technologies and strategic partnerships.
Al Raqbani highlighted Globalpharma's focus on empowering Emirati talent, noting collaborations with both local and international institutions to train professionals in the pharmaceutical sector. He credited the UAE's leadership for investing in human capital, saying this approach is yielding strong local capabilities in key industries.
The company's commitment to excellence was underscored by its recent win at the Make it in the Emirates Awards, where it received the Pharmaceutical Quality Award for adhering to top-tier global standards.
All of Globalpharma's products are fully manufactured in the UAE, with operations based in Dubai Investments Park. The company is expanding into the development of biological drugs and herbal treatments inspired by Emirati heritage.
During the forum, Globalpharma signed four new agreements with partners in Canada, Spain, Egypt, and Jordan. These deals aim to boost the company's global presence and reinforce the UAE's status as a hub for high-quality pharmaceutical production.
Al Raqbani reaffirmed Globalpharma's commitment to strengthening the UAE's pharmaceutical security and praised the forum as a vital platform for collaboration, innovation, and industrial growth.
News Source: Emirates News Agency
